Dunkin’ has now dropped its holiday menu, featuring nine new items as well as returning favorites. The first part of the menu will drop Nov. 5, 2025, and the second part will debut Dec. 3, according ...

100 Buffet opens to Pensacola at 11 a.m. on Oct. 10 at 19 N. Navy Blvd. All dishes are prepared fresh on a constant rotation throughout the day, from piping hot stir-fries to cool hand-rolled sushi.

Starbucks dropped its holiday menu for 2025, and there will be a lot of fan-favorite items returning to the menu. Starting Nov. 6, the coffee chain will bring back the the Peppermint Mocha, Caramel ...

Their putting their menu where their slogan is with more meats. Arby's has introduced a new bite-sized protein with its first-ever Steak Nuggets. Starting Monday, the fast food chain, whose slogan is ...

New menu items remain a way for restaurant brands to remain relevant as the dining sector becomes increasingly competitive. While some consumers are reeling back spending in the restaurant and retail ...

The Peppermint Mocha, Caramel Brulée Latte, Iced Sugar Cookie Latte and Iced Gingerbread Chai will all be making a festive comeback Starbucks Starbucks' 2025 holiday menu, revealed on Monday, Oct. 6, ...

Investing.com - Citizens has reiterated its Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ:LRMR), following a call with the CEO of the Friedreich’s Ataxia Research ...

Olive Garden, which has traditionally seen success from its annual unlimited pasta promotion, recently noticed the opposite trend: Some customers actually wanted less food. Last quarter, the ...

Your next burger-and-nug trip could be absolutely ooky-spooky. On Sept. 29, Burger King announced its first-ever Monster Menu, featuring four “hauntingly tasty twists” on fan-favorite items, all ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Larimar Therapeutics ( (LRMR)) has issued ...

Investing.com -- Larimar Therapeutics Inc (NASDAQ:LRMR) stock plummeted 22.5% on Monday after the company revealed seven participants experienced anaphylaxis in its ongoing open-label study of ...

BALA CYNWYD, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...